Manages chronic stable angina and angina due to coronary artery spasm. ANDA 74093, held by Chartwell Molecules. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74093 (Diltiazem Hydrochloride), held by Chartwell Molecules, was first approved by FDA on Nov 5, 1992, with 14 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Diltiazem hydrochloride is indicated for the management of chronic stable angina and angina due to coronary artery spasm.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 5, 1992 | Original application | Approved | None posted |
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride90MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride120MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Oct 4, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Jan 29, 1998 | Supplement 13Manufacturing | Approved | None posted |
| Jan 28, 1997 | Supplement 12Labeling | Approved | None posted |
| Jan 16, 1997 | Supplement 11Labeling | Approved | None posted |
| Dec 11, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Apr 29, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Nov 15, 1995 | Supplement 8Labeling | Approved | None posted |
| Nov 7, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Nov 7, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Feb 8, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Nov 23, 1994 | Supplement 4Manufacturing | Approved | None posted |
| Nov 23, 1994 | Supplement 3Manufacturing | Approved | None posted |
| May 10, 1994 | Supplement 1Labeling | Approved | None posted |
| Apr 28, 1994 | Supplement 2Manufacturing | Approved | None posted |
| Nov 5, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters